EU backs development of molecular Dx test for malaria

09/25/2013 | GenomeWeb Daily News (free registration)

Forsite Diagnostics will use a $728,438 grant from the European Commission to support the development of a molecular test to diagnose malaria quickly. The company is developing the blood-based assay for use in detecting Plasmodium falciparum or Plasmodium vivaxis parasites, which trigger malaria, to help doctors prescribe appropriate treatments immediately.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT